BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marjot T, Webb GJ, Barritt AS 4th, Moon AM, Stamataki Z, Wong VW, Barnes E. COVID-19 and liver disease: mechanistic and clinical perspectives. Nat Rev Gastroenterol Hepatol 2021;18:348-64. [PMID: 33692570 DOI: 10.1038/s41575-021-00426-4] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 100.0] [Reference Citation Analysis]
Number Citing Articles
1 Singh A, De A, Singh MP, Rathi S, Verma N, Premkumar M, Taneja S, Duseja A, Singh V. Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study. Dig Dis Sci. [DOI: 10.1007/s10620-022-07641-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Minata M, Harada KH, Yamaguchi T, Fujitani T, Nakagawa H. Diabetes Mellitus May Exacerbate Liver Injury in Patients with COVID-19: A Single-Center, Observational, Retrospective Study. Diabetes Ther 2022. [PMID: 36136238 DOI: 10.1007/s13300-022-01318-9] [Reference Citation Analysis]
3 Zhong H, Zhou Y, Mei S, Tang R, Feng J, He Z, Xu Q, Xing S. Scars of COVID-19: A bibliometric analysis of post-COVID-19 fibrosis. Front Public Health 2022;10:967829. [DOI: 10.3389/fpubh.2022.967829] [Reference Citation Analysis]
4 da Costa VD, Wiggers WJ, Ivantes CAP, da Fonseca RJM, Dávila AMR, Moreira OC, Ferreira BIDS, de Paula VS, da Silva LL, Santos AC, Villar LM. Characteristics of COVID-19 Infection in a Hospitalized Autoimmune Hepatitis Patient. Pathogens 2022;11:1054. [DOI: 10.3390/pathogens11091054] [Reference Citation Analysis]
5 Mauro A, De Grazia F, Anderloni A, Di Sabatino A. Upper gastrointestinal bleeding in coronavirus disease 2019 patients. Curr Opin Gastroenterol 2022;38:443-9. [PMID: 35916320 DOI: 10.1097/MOG.0000000000000859] [Reference Citation Analysis]
6 Liu J, Zhang L, Gao J, Zhang B, Liu X, Yang N, Liu X, Liu X, Cheng Y. Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis. Front Pharmacol 2022;13:961154. [DOI: 10.3389/fphar.2022.961154] [Reference Citation Analysis]
7 Afewerki S, Stocco TD, Rosa da Silva AD, Aguiar Furtado AS, Fernandes de Sousa G, Ruiz-Esparza GU, Webster TJ, Marciano FR, Strømme M, Zhang YS, Lobo AO. In vitro high-content tissue models to address precision medicine challenges. Mol Aspects Med 2022;:101108. [PMID: 35987701 DOI: 10.1016/j.mam.2022.101108] [Reference Citation Analysis]
8 Mercado-Gómez M, Prieto-Fernández E, Goikoetxea-Usandizaga N, Vila-Vecilla L, Azkargorta M, Bravo M, Serrano-Maciá M, Egia-Mendikute L, Rodríguez-Agudo R, Lachiondo-Ortega S, Lee SY, Eguileor Giné A, Gil-Pitarch C, González-Recio I, Simón J, Petrov P, Jover R, Martínez-Cruz LA, Ereño-Orbea J, Delgado TC, Elortza F, Jiménez-Barbero J, Nogueiras R, Prevot V, Palazon A, Martínez-Chantar ML. The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes. Commun Biol 2022;5:827. [PMID: 35978143 DOI: 10.1038/s42003-022-03789-9] [Reference Citation Analysis]
9 Zhu M, Chen L. Hepatitis of unknown etiology in children: What we know and what we can do? Front Microbiol 2022;13:956887. [DOI: 10.3389/fmicb.2022.956887] [Reference Citation Analysis]
10 Jia K, Wu J, Li Y, Liu J, Liu R, Cai Y, Zhang Y, Li X. A novel pulmonary fibrosis murine model with immune-related liver injury. Animal Model Exp Med 2022. [PMID: 35934841 DOI: 10.1002/ame2.12263] [Reference Citation Analysis]
11 Chen H, Chen Q. COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2 Infection and MAFLD. Int J Biol Sci 2022;18:4756-67. [PMID: 35874945 DOI: 10.7150/ijbs.72461] [Reference Citation Analysis]
12 Marjot T, Eberhardt CS, Boettler T, Belli LS, Berenguer M, Buti M, Jalan R, Mondelli MU, Moreau R, Shouval D, Berg T, Cornberg M. Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper. J Hepatol 2022:S0168-8278(22)02942-7. [PMID: 35868584 DOI: 10.1016/j.jhep.2022.07.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Rahnavard A, Mann B, Giri A, Chatterjee R, Crandall KA. Metabolite, protein, and tissue dysfunction associated with COVID-19 disease severity. Sci Rep 2022;12:12204. [PMID: 35842456 DOI: 10.1038/s41598-022-16396-9] [Reference Citation Analysis]
14 Qi X, Wang J, Zhang Q, Ai J, Liu C, Li Q, Gu Y, Lv J, Huang Y, Liu Y, Xu D, Chen S, Liu D, Li J, Xiang H, Liang J, Bian L, Zhang Z, Liu L, Zhang X, Qin W, Wang X, Hou Z, Zhang N, Zhang A, Zu H, Wang Y, Yan Z, Du X, Hou A, Ji J, Yang J, Huang J, Zhao Z, Zou S, Ji H, Ge G, Zeng QL, Zhang W. Safety and immunogenicity of COVID-19 vaccination in patients with hepatocellular carcinoma (CHESS-NMCID 2101): A multicenter prospective study. J Med Virol 2022. [PMID: 35811309 DOI: 10.1002/jmv.27992] [Reference Citation Analysis]
15 Liu Y, Wang K, Yang L, He D. Regional heterogeneity of in-hospital mortality of COVID-19 in Brazil. Infectious Disease Modelling 2022. [DOI: 10.1016/j.idm.2022.06.005] [Reference Citation Analysis]
16 Luo M, Ballester MP, Soffientini U, Jalan R, Mehta G. SARS-CoV-2 infection and liver involvement. Hepatol Int 2022. [PMID: 35767172 DOI: 10.1007/s12072-022-10364-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Sahu T, Pande B, PL M, Verma HK. Liver dysfunction during COVID-19 pandemic: Contributing role of associated factors in disease progression and severity. World J Hepatol 2022; 14(6): 1099-1110 [DOI: 10.4254/wjh.v14.i6.1099] [Reference Citation Analysis]
18 Sripongpun P, Pinpathomrat N, Bruminhent J, Kaewdech A. Coronavirus Disease 2019 Vaccinations in Patients With Chronic Liver Disease and Liver Transplant Recipients: An Update. Front Med 2022;9:924454. [DOI: 10.3389/fmed.2022.924454] [Reference Citation Analysis]
19 Dufour JF, Marjot T, Becchetti C, Tilg H. COVID-19 and liver disease. Gut 2022:gutjnl-2021-326792. [PMID: 35701093 DOI: 10.1136/gutjnl-2021-326792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
20 Burra P, Russo FP. Sars-Cov-2 vaccination in liver transplant recipients: The 'holy grail' in a hostile environment. Liver Int 2022;42:1225-8. [PMID: 35678039 DOI: 10.1111/liv.15226] [Reference Citation Analysis]
21 Osborn J, Szabo S, Peters AL. Pediatric Acute Liver Failure Due to Type 2 Autoimmune Hepatitis Associated With SARS-CoV-2 Infection: A Case Report. JPGN Rep 2022;3:e204. [PMID: 35505826 DOI: 10.1097/PG9.0000000000000204] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Chen C, Riyahi S, Prince M, Thomas C, RoyChoudury A, Browne WF, Sweeney E, Margolis DJ. Predictors of biliary intervention in patients hospitalized for COVID-19. Abdom Radiol (NY) 2022;47:1891-8. [PMID: 35234995 DOI: 10.1007/s00261-022-03461-0] [Reference Citation Analysis]
23 Yuan WZ, Fu T. Liver Dysfunction in COVID-19: From Onset to Recovery. Semin Liver Dis 2022;42:151-8. [PMID: 35738256 DOI: 10.1055/s-0042-1745871] [Reference Citation Analysis]
24 Russo FP, Burra P, Zanetto A. COVID-19 and liver disease: where are we now? Nat Rev Gastroenterol Hepatol 2022;19:277-8. [PMID: 35301465 DOI: 10.1038/s41575-022-00607-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Brozat JF, Hanses F, Haelberger M, Stecher M, Dreher M, Tometten L, Ruethrich MM, Vehreschild JJ, Trautwein C, Borgmann S, Vehreschild MJGT, Jakob CEM, Stallmach A, Wille K, Hellwig K, Isberner N, Reuken PA, Geisler F, Nattermann J, Bruns T; LEOSS study group. COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry. United European Gastroenterol J 2022. [PMID: 35482663 DOI: 10.1002/ueg2.12232] [Reference Citation Analysis]
26 Teschke R, Méndez-Sánchez N, Eickhoff A. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method. Int J Mol Sci 2022;23:4828. [PMID: 35563242 DOI: 10.3390/ijms23094828] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
27 Vázquez-Medina MU, Cerda-Reyes E, Galeana-Pavón A, López-Luna CE, Ramírez-Portillo PM, Ibañez-Cervantes G, Torres-Vázquez J, Vargas-De-León C. Interaction of metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease with advanced fibrosis in the death and intubation of patients hospitalized with coronavirus disease 2019. Hepatol Commun 2022. [PMID: 35438253 DOI: 10.1002/hep4.1957] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Liao X, Li D, Ma Z, Zhang L, Zheng B, Li Z, Li G, Liu L, Zhang Z. 12-Month Post-Discharge Liver Function Test Abnormalities Among Patients With COVID-19: A Single-Center Prospective Cohort Study. Front Cell Infect Microbiol 2022;12:864933. [DOI: 10.3389/fcimb.2022.864933] [Reference Citation Analysis]
29 Wang J, Zhang Q, Ai J, Liu D, Liu C, Xiang H, Gu Y, Guo Y, Lv J, Huang Y, Liu Y, Xu D, Chen S, Li J, Li Q, Liang J, Bian L, Zhang Z, Guo X, Feng Y, Liu L, Zhang X, Zhang Y, Xie F, Jiang S, Qin W, Wang X, Rao W, Zhang Q, Tian Q, Zhu Y, Cong Q, Xu J, Hou Z, Zhang N, Zhang A, Zu H, Wang Y, Yan Z, Du X, Hou A, Yan Y, Qiu Y, Wu H, Hu S, Deng Y, Ji J, Yang J, Huang J, Zhao Z, Zou S, Ji H, Ge G, Zhong L, He S, Yan X, Yangzhen BB, Qu C, Zhang L, Yang S, Gao X, Lv M, Zhu Q, Xu X, Zeng Q, Qi X, Zhang W. Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study. Hepatol Int. [DOI: 10.1007/s12072-022-10332-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. The Lancet Diabetes & Endocrinology 2022;10:284-96. [DOI: 10.1016/s2213-8587(22)00003-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 25.0] [Reference Citation Analysis]
31 Yao L, Lu L, Ma W. Immunopathological changes, complications, sequelae and immunological memory in COVID-19 patients. Heliyon 2022;8:e09302. [PMID: 35497026 DOI: 10.1016/j.heliyon.2022.e09302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Zhu X, Wang J, Du J, Chen S, Chen S, Li J, Shen B. Changes in Serum Liver Function for Patients with COVID-19: A 1-Year Follow-Up Study. IDR 2022;Volume 15:1857-70. [DOI: 10.2147/idr.s356181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Davies A, Åsenius F, Purcell F, Wu M, Al-rubaye A, Alrubaiy L. THE PATTERN AND LONG TERM FOLLOW UP OF COVID-19 RELATED ABNORMAL LIVER BLOOD TESTS. ijsr. [DOI: 10.36106/ijsr/6020892] [Reference Citation Analysis]
34 Diaz-Louzao C, Barrera-Lopez L, Lopez-Rodriguez M, Casar C, Vazquez-Agra N, Pernas-Pardavila H, Marques-Afonso A, Vidal-Vazquez M, Montoya JG, Andrade AH, Fernandez-Castro I, Varela P, Gonzalez-Quintela A, Otero E, Gude F, Cadarso-Suarez C, Tome S. Longitudinal relationship of liver injury with inflammation biomarkers in COVID-19 hospitalized patients using a joint modeling approach. Sci Rep 2022;12:5547. [PMID: 35365705 DOI: 10.1038/s41598-022-09290-x] [Reference Citation Analysis]
35 Barnes E. Infection of liver hepatocytes with SARS-CoV-2. Nat Metab 2022. [PMID: 35347317 DOI: 10.1038/s42255-022-00554-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Shivshankar P, Karmouty-Quintana H, Mills T, Doursout MF, Wang Y, Czopik AK, Evans SE, Eltzschig HK, Yuan X. SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets. Inflammation 2022. [PMID: 35320469 DOI: 10.1007/s10753-022-01656-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
37 Wong CKH, Au ICH, Cheng WY, Man KKC, Lau KTK, Mak LY, Lui SL, Chung MSH, Xiong X, Lau EHY, Cowling BJ. Remdesivir use and risks of acute kidney injury and acute liver injury among patients hospitalised with COVID-19: A self-controlled case series study. Aliment Pharmacol Ther 2022. [PMID: 35318694 DOI: 10.1111/apt.16894] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
38 Moreno-Fernandez J, Ochoa J, Ojeda ML, Nogales F, Carreras O, Díaz-Castro J. Inflammation and oxidative stress, the links between obesity and COVID-19: a narrative review. J Physiol Biochem 2022. [PMID: 35316507 DOI: 10.1007/s13105-022-00887-4] [Reference Citation Analysis]
39 Shousha HI, Ramadan A, Lithy R, El-Kassas M. Patterns of liver profile disturbance in patients with COVID-19 . World J Clin Cases 2022; 10(7): 2063-2071 [DOI: 10.12998/wjcc.v10.i7.2063] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Yip TC, Gill M, Wong GL, Liu K. Management of hepatitis B virus reactivation due to treatment of COVID-19. Hepatol Int 2022. [PMID: 35235148 DOI: 10.1007/s12072-022-10306-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Punga D, Isac S, Paraipan C, Cotorogea M, Stefan A, Cobilinschi C, Vacaroiu IA, Tulin R, Ionescu D, Droc G. Impact of COVID-19 Infection on Liver Transplant Recipients: Does It Make Any Difference? Cureus. [DOI: 10.7759/cureus.22687] [Reference Citation Analysis]
42 Kaviani M, Keshtkar S, Soleimanian S, Sabet Sarvestani F, Azarpira N, Pakbaz S. Susceptibility to Metabolic Diseases in COVID-19: To be or Not to be an Issue. Front Mol Biosci 2022;9:803314. [DOI: 10.3389/fmolb.2022.803314] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Liu M, Huang Q, Zhu Y, Chen L, Li Y, Gong Z, Ai K. Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
44 Ahmad Malik J, Ahmed S, Shinde M, Hajjaj Saeid Al-marmash M, Alghamdi S, Hussain A, Anwar S. The impact of COVID-19 on the comorbidities: A review of recent updates for combating it. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2022.02.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
45 Bakasis A, Bitzogli K, Mouziouras D, Pouliakis A, Roumpoutsou M, Goules AV, Androutsakos T. Antibody Responses after SARS-CoV-2 Vaccination in Patients with Liver Diseases. Viruses 2022;14:207. [DOI: 10.3390/v14020207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
46 Alkattan W, Yaqinuddin A, Shafqat A, Kashir J. NET-Mediated Pathogenesis of COVID-19: The Role of NETs in Hepatic Manifestations. Journal of Health and Allied Sciences NU. [DOI: 10.1055/s-0041-1741418] [Reference Citation Analysis]
47 Padmaprakash K, Thareja S, Raman N, Sowmya Karantha C, Muthukrishnan J, Vardhan V. “Does Transaminitis Predict Severity and Mortality in COVID 19 Patients?”. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Taneva G, Dimitrov D, Velikova T. Liver dysfunction as a cytokine storm manifestation and prognostic factor for severe COVID-19. World J Hepatol 2021; 13(12): 2005-2012 [DOI: 10.4254/wjh.v13.i12.2005] [Reference Citation Analysis]
49 Sohrabi M, SobheRakhshankhah E, Ziaei H, AtaeeKachuee M, Zamani F. Acute liver failure after vaccination against of COVID-19; a case report and review literature. Respir Med Case Rep 2022;35:101568. [PMID: 34926142 DOI: 10.1016/j.rmcr.2021.101568] [Reference Citation Analysis]
50 He F, Page JH, Weinberg KR, Mishra A. Development and validation of simplified machine learning algorithms to predict prognosis of hospitalized COVID-19 patients: a multi-center, retrospective study. J Med Internet Res 2021. [PMID: 34951865 DOI: 10.2196/31549] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Venegas-Borsellino C, Sankararaman S, Roche K, Burns J, Landis RM. Impact of COVID-19 on the Intestinal Microbiome. Curr Nutr Rep 2021;10:300-6. [PMID: 34813042 DOI: 10.1007/s13668-021-00375-z] [Reference Citation Analysis]
52 Brady M, McQuaid C, Solorzano A, Johnson A, Combs A, Venkatraman C, Rahman A, Leyva H, Kwok WE, Wood RW, Deane R. Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2. Commun Biol 2021;4:1318. [PMID: 34811493 DOI: 10.1038/s42003-021-02856-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Liu D, Zhang Q, Bai P, Zhao J. Assessing causal relationships between COVID-19 and non-alcoholic fatty liver disease. J Hepatol 2021:S0168-8278(21)02218-2. [PMID: 34813919 DOI: 10.1016/j.jhep.2021.11.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Tranah TH, Kronsten VT, Shawcross DL. Implications and Management of Cirrhosis-Associated Immune Dysfunction Before and After Liver Transplantation. Liver Transpl 2021. [PMID: 34738724 DOI: 10.1002/lt.26353] [Reference Citation Analysis]
55 Ruiz I, Huard G, Fournier C, Bissonnette J, Castel H, Giard J, Villeneuve J, Fenyves D, Marleau D, Willems B, Corsilli D, Correal F, Ferreira V, Martel D, Mathieu A, Vincent C, Bilodeau M. A real-world experience of SARS-CoV-2 infection in a tertiary referral centre of Montréal: Unexpected low prevalence and low mortality. CanLivJ 2021;4:391-400. [DOI: 10.3138/canlivj-2021-0022] [Reference Citation Analysis]
56 Moon AM, Webb GJ, García-Juárez I, Kulkarni AV, Adali G, Wong DK, Lusina B, Dalekos GN, Masson S, Shore BM, Barnes E, Barritt AS 4th, Marjot T. SARS-CoV-2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID-19 Vaccination. Hepatol Commun 2021. [PMID: 34708575 DOI: 10.1002/hep4.1853] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
57 Gaspar R, Castelo Branco C, Macedo G. Liver and COVID-19: From care of patients with liver diseases to liver injury. World J Hepatol 2021; 13(10): 1367-1377 [PMID: 34786172 DOI: 10.4254/wjh.v13.i10.1367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
58 Veleri S. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients. Exp Brain Res 2021. [PMID: 34694467 DOI: 10.1007/s00221-021-06244-z] [Reference Citation Analysis]
59 Dehghani S, Teimouri A. Severe Acute Hepatitis in a COVID-19 patient: A Case Report. Clin Case Rep 2021;9:e04869. [PMID: 34667602 DOI: 10.1002/ccr3.4869] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Rahban M, Stanek A, Hooshmand A, Khamineh Y, Ahi S, Kazim SN, Ahmad F, Muronetz V, Samy Abousenna M, Zolghadri S, Saboury AA. Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients. J Clin Med 2021;10:4802. [PMID: 34768321 DOI: 10.3390/jcm10214802] [Reference Citation Analysis]
61 McConnell MJ, Kondo R, Kawaguchi N, Iwakiri Y. Covid-19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis. Hepatol Commun 2021. [PMID: 34658172 DOI: 10.1002/hep4.1843] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
62 Wang X, Lei J, Li Z, Yan L. Potential Effects of Coronaviruses on the Liver: An Update. Front Med (Lausanne) 2021;8:651658. [PMID: 34646834 DOI: 10.3389/fmed.2021.651658] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
63 Kolesova O, Vanaga I, Laivacuma S, Derovs A, Kolesovs A, Radzina M, Platkajis A, Eglite J, Hagina E, Arutjunana S, Putrins DS, Storozenko J, Rozentale B, Viksna L. Intriguing findings of liver fibrosis following COVID-19. BMC Gastroenterol 2021;21:370. [PMID: 34635073 DOI: 10.1186/s12876-021-01939-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
64 Miele L, Napodano C, Cesario A, De Magistris A, Pocino K, Basile U, Rapaccini GL, Gasbarrini A, Grieco A. COVID-19, adaptative immune response and metabolic-associated liver disease. Liver Int 2021;41:2560-77. [PMID: 34555255 DOI: 10.1111/liv.15061] [Reference Citation Analysis]
65 Paštrovic F, Lucijanic M, Atic A, Stojic J, Barisic Jaman M, Tjesic Drinkovic I, Zelenika M, Milosevic M, Medic B, Loncar J, Mijic M, Filipec Kanizaj T, Kralj D, Lerotic I, Virovic Jukic L, Ljubicic N, Luetic K, Grgic D, Majerovic M, Ostojic R, Krznaric Z, Luksic I, Piskac Zivkovic N, Keres T, Grabovac V, Persec J, Barsic B, Grgurevic I. Prevalence and Prognostic Impact of Deranged Liver Blood Tests in COVID-19: Experience from the Regional COVID-19 Center over the Cohort of 3812 Hospitalized Patients. J Clin Med 2021;10:4222. [PMID: 34575333 DOI: 10.3390/jcm10184222] [Reference Citation Analysis]
66 Nikitopoulou I, Fanidis D, Ntatsoulis K, Moulos P, Mpekoulis G, Evangelidou M, Vassiliou AG, Dimakopoulou V, Jahaj E, Tsipilis S, Orfanos SE, Dimopoulou I, Angelakis E, Akinosoglou K, Vassilaki N, Tzouvelekis A, Kotanidou A, Aidinis V. Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells. Int J Mol Sci 2021;22:10006. [PMID: 34576169 DOI: 10.3390/ijms221810006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Kardani K, Bolhassani A, Kardani M, Agi E; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran, Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran, Iranian Comprehensive Hemophilia Care Center, Tehran, Iran. Correlation of SARS-CoV-2 Infection with Hepatitis and Liver Disorders. JoMMID 2021;9:122-32. [DOI: 10.52547/jommid.9.3.122] [Reference Citation Analysis]
68 Pirola CJ, Sookoian S. PNPLA3 and COVID-19 outcomes: Thinking outside the box might explain the biology behind pleiotropic effects of rs738409 on the immune system. Liver Int 2021;41:2801-4. [PMID: 34455682 DOI: 10.1111/liv.15043] [Reference Citation Analysis]
69 Paidas MJ, Mohamed AB, Norenberg MD, Saad A, Barry AF, Colon C, Kenyon NS, Jayakumar AR. Multi-Organ Histopathological Changes in a Mouse Hepatitis Virus Model of COVID-19. Viruses 2021;13:1703. [PMID: 34578284 DOI: 10.3390/v13091703] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
70 Basu A, Pamreddy A, Singh P, Sharma K. An Adverse Outcomes Approach to Study the Effects of SARS-CoV-2 in 3D Organoid Models. J Mol Biol 2021;:167213. [PMID: 34437890 DOI: 10.1016/j.jmb.2021.167213] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 Qu J, Zhu HH, Huang XJ, He GF, Liu JY, Huang JJ, Chen Y, Qu Q, Wu YL, Chen XY, Lu Q. Abnormal Indexes of Liver and Kidney Injury Markers Predict Severity in COVID-19 Patients. Infect Drug Resist 2021;14:3029-40. [PMID: 34408447 DOI: 10.2147/IDR.S321915] [Reference Citation Analysis]
72 Yaneske E, Zampieri G, Bertoldi L, Benvenuto G, Angione C. Genome-scale metabolic modelling of SARS-CoV-2 in cancer cells reveals an increased shift to glycolytic energy production. FEBS Lett 2021;595:2350-65. [PMID: 34409594 DOI: 10.1002/1873-3468.14180] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
73 Phipps MM, Verna EC. Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic. Liver Transpl 2021;27:1312-25. [PMID: 34096188 DOI: 10.1002/lt.26194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
74 Spearman CW, Aghemo A, Valenti L, Sonderup MW. COVID-19 and the liver: A 2021 update. Liver Int 2021;41:1988-98. [PMID: 34152690 DOI: 10.1111/liv.14984] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Magdy Beshbishy A, Oti VB, Hussein DE, Rehan IF, Adeyemi OS, Rivero-Perez N, Zaragoza-Bastida A, Shah MA, Abouelezz K, Hetta HF, Cruz-Martins N, Batiha GE. Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review. Front Public Health 2021;9:591982. [PMID: 34307267 DOI: 10.3389/fpubh.2021.591982] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
76 McGrowder DA, Miller F, Anderson Cross M, Anderson-Jackson L, Bryan S, Dilworth L. Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis. Diseases 2021;9:50. [PMID: 34287285 DOI: 10.3390/diseases9030050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Piedade J, Pereira G. COVID-19 in liver transplant recipients. Journal of Liver Transplantation 2021;3:100026. [DOI: 10.1016/j.liver.2021.100026] [Reference Citation Analysis]
78 Magro F, Nuzzo A, Abreu C, Libânio D, Rodriguez-Lago I, Pawlak K, Hollenbach M, Brouwer WP, Siau K. COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology. United European Gastroenterol J 2021. [PMID: 34190413 DOI: 10.1002/ueg2.12115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
79 Sica R, Pennoni S, Penta L, Di Cara G, Verrotti A. New Onset of Hepatic Steatosis Post-Severe Multisystem Inflammatory Syndrome in Children (MIS-C): A Case Report. Int J Environ Res Public Health 2021;18:6961. [PMID: 34209719 DOI: 10.3390/ijerph18136961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Sharma A, Patnaik I, Kumar A, Gupta R. COVID-19 vaccines in patients with chronic liver disease. J Clin Exp Hepatol. 2021;. [PMID: 34177192 DOI: 10.1016/j.jceh.2021.06.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
81 Wang X, Chen CH, Badeti S, Cho JH, Naghizadeh A, Wang Z, Liu D. Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell-cell fusion. Cell Biosci 2021;11:114. [PMID: 34162440 DOI: 10.1186/s13578-021-00626-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 D'Amico FE, Glavas D, Noaro G, Bassi D, Boetto R, Gringeri E, De Luca M, Cillo U. Case Report: Liver Cysts and SARS-CoV-2: No Evidence of Virus in Cystic Fluid. Front Surg 2021;8:677889. [PMID: 34222319 DOI: 10.3389/fsurg.2021.677889] [Reference Citation Analysis]
83 Cerbu B, Pantea S, Bratosin F, Vidican I, Turaiche M, Frent S, Borsi E, Marincu I. Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of Pandemic. Medicina (Kaunas) 2021;57:597. [PMID: 34200570 DOI: 10.3390/medicina57060597] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
84 Ding ZY, Li GX, Shu C, Yin P, Zhang B; Tongji multidisciplinary Team for Treating COVID-19 (TTTC). Reply to: Comments on "Association of liver abnormalities with in-hospital mortality in patients with COVID-19". J Hepatol 2021;75:742-4. [PMID: 34090927 DOI: 10.1016/j.jhep.2021.05.027] [Reference Citation Analysis]
85 Moon AM, Curtis B, Mandrekar P, Singal AK, Verna EC, Fix OK. Alcohol-Associated Liver Disease Before and After COVID-19-An Overview and Call for Ongoing Investigation. Hepatol Commun 2021. [PMID: 34222743 DOI: 10.1002/hep4.1747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
86 Punj S, Eng E, Shetty AA. Coronavirus disease 2019 and kidney injury. Curr Opin Nephrol Hypertens 2021;30:444-9. [PMID: 34027906 DOI: 10.1097/MNH.0000000000000718] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Chen CH, Badeti S, Cho JH, Naghizadeh A, Wang X, Liu D. Deletion of ER-retention Motif on SARS-CoV-2 Spike Protein Reduces Cell Hybrid During Cell-cell Fusion. Res Sq 2021:rs. [PMID: 33851149 DOI: 10.21203/rs.3.rs-380389/v1] [Reference Citation Analysis]
88 Mallet M, Allaire M, Thabut D, Rudler M. Liver damage associated with Covid-19: A direct causality is difficult to establish. Journal of Liver Transplantation 2021;2:100011. [DOI: 10.1016/j.liver.2021.100011] [Reference Citation Analysis]
89 Zamani F, Mansoorian M, Pishgar E, Sahraei R, Rahimian N, Alibeik N. Successful liver transplant in a patient with acute cholestatic liver failure due to COVID-19 infection: A case report. Journal of Liver Transplantation 2021;2:100007. [DOI: 10.1016/j.liver.2021.100007] [Reference Citation Analysis]